Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Acq. announced Appointed director Notes underwriting agrmnt
|
Kura Oncology, Inc. (KURA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.9% stake in Kura Oncology, Inc. |
02/10/2023 |
SC 13G/A
| Flynn James E reports a 3.6% stake in Kura Oncology, Inc. |
02/03/2023 |
SC 13G/A
| STATE STREET CORP reports a 6.6% stake in AMENDED FILING KURA ONCOLOGY INC |
01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in Kura Oncology Inc |
03/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 5.4% stake in Kura Oncology, Inc. |
02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/10/2022 |
SC 13G/A
| FMR LLC reports a 8.4% stake in KURA ONCOLOGY INC |
02/16/2021 |
SC 13G/A
| EcoR1 Capital, LLC reports a 2.7% stake in Kura Oncology, Inc. |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2021 |
SC 13G/A
| VICTORY CAPITAL MANAGEMENT INC reports a 2.8% stake in KURA ONCOLOGY INC |
01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in KURA ONCOLOGY, INC |
01/28/2021 |
SC 13G/A
| WILSON TROY EDWARD reports a 3.3% stake in Kura Oncology, Inc. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| EcoR1 Capital, LLC reports a 9.4% stake in Kura Oncology, Inc. |
02/07/2020 |
SC 13G/A
| FMR LLC reports a 15% stake in KURA ONCOLOGY INC |
02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.6% stake in KURA ONCOLOGY, INC |
01/31/2020 |
SC 13G/A
| WILSON TROY EDWARD reports a 5.8% stake in Kura Oncology, Inc. |
12/17/2019 |
SC 13G/A
| EAGLE ASSET MANAGEMENT INC reports a 4.6% stake in , attached please find a copy of for the above named company showing a change of beneficial ownership as of 12/17/2019 filed on behalf of Eagle Asset Management, Inc. Very truly yours, Damian Sousa Vice President Chief Compliance Officer DS:CC Enclosures cc: Office of the Corporate Secretary Kura Oncology Inc. 3033 Science Park Road Suite 220 San Diego CA 92121 Kura Oncology Inc. |
07/10/2019 |
SC 13G/A
| FMR LLC reports a 10.8% stake in KURA ONCOLOGY INC |
02/14/2019 |
SC 13G/A
| Partner Fund Management, L.P. reports a 3% stake in Kura Oncology, Inc. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| ARCH Venture Fund VIII, L.P. has filed a Schedule 13D for Kura Oncology, Inc. |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2019 |
SC 13G/A
| WILSON TROY EDWARD reports a 6.3% stake in Kura Oncology, Inc. |
07/10/2018 |
SC 13G/A
| FMR LLC reports a 9.1% stake in KURA ONCOLOGY INC |
03/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|